| Dr Albert Victor Porambo, MD | |
|
3905 Fox Valley Dr, Rockville, MD 20853-3206 | |
| (301) 774-4764 | |
| Not Available |
| Full Name | Dr Albert Victor Porambo |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 36 Years |
| Location | 3905 Fox Valley Dr, Rockville, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285670158 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | D0040902 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Radiology Associates Inc | 5991692444 | 41 |
| Community Radiology Associates Inc | 5991692444 | 41 |
News Archive
Aileron Therapeutics, Inc. today announced new preclinical data demonstrating that ATSP-9172, its Stapled Peptide inhibitor of HIF-1α-dependent transcription, exhibits on-target binding activity, favorable pharmacokinetic properties and potent in vivo efficacy in a human prostate cancer model.
Moerae Matrix Inc. announced today the initiation of its second Phase 1 clinical trial with MMI-0100, a first-in-class inhibitor of MAPKAP kinase 2 (MK2) that is being developed for pulmonary disorders characterized by inflammation and fibrosis. The study, conducted in the United Kingdom, is a double-blind, two-way cross-over design lipopolysaccharide (LPS) challenge study further evaluating the safety and tolerability of MMI-0100 when given via inhalation to healthy subjects who smoke.
If dead cells accumulate in the body, they can contribute to inflammation and pre-dispose individuals to multiple chronic inflammatory conditions such as rheumatoid arthritis, cardiovascular diseases, Crohn's disease or lupus by uncharacterized pathways.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Schering-Plough's brain tumor treatment Temodar® (temozolomide). The Court found that U.S. Patent No. 5,260,291 is not enforceable due to prosecution laches and inequitable conduct.
A radiologic technology, which functions like a 'human GPS system,' and provides more precise results while using less radiation, is being used to treat patients with symptomatic uterine fibroids exclusively at Paoli Hospital. Dr. Atul Gupta, director of interventional radiology, is treating patients as part of a first-ever clinical trial.
› Verified 7 days ago
| Entity Name | Clinical Radiologists Medical Imaging Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871503912 PECOS PAC ID: 3173429701 Enrollment ID: O20031212000209 |
News Archive
Aileron Therapeutics, Inc. today announced new preclinical data demonstrating that ATSP-9172, its Stapled Peptide inhibitor of HIF-1α-dependent transcription, exhibits on-target binding activity, favorable pharmacokinetic properties and potent in vivo efficacy in a human prostate cancer model.
Moerae Matrix Inc. announced today the initiation of its second Phase 1 clinical trial with MMI-0100, a first-in-class inhibitor of MAPKAP kinase 2 (MK2) that is being developed for pulmonary disorders characterized by inflammation and fibrosis. The study, conducted in the United Kingdom, is a double-blind, two-way cross-over design lipopolysaccharide (LPS) challenge study further evaluating the safety and tolerability of MMI-0100 when given via inhalation to healthy subjects who smoke.
If dead cells accumulate in the body, they can contribute to inflammation and pre-dispose individuals to multiple chronic inflammatory conditions such as rheumatoid arthritis, cardiovascular diseases, Crohn's disease or lupus by uncharacterized pathways.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Schering-Plough's brain tumor treatment Temodar® (temozolomide). The Court found that U.S. Patent No. 5,260,291 is not enforceable due to prosecution laches and inequitable conduct.
A radiologic technology, which functions like a 'human GPS system,' and provides more precise results while using less radiation, is being used to treat patients with symptomatic uterine fibroids exclusively at Paoli Hospital. Dr. Atul Gupta, director of interventional radiology, is treating patients as part of a first-ever clinical trial.
› Verified 7 days ago
| Entity Name | Community Radiology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396707782 PECOS PAC ID: 5991692444 Enrollment ID: O20040301000769 |
News Archive
Aileron Therapeutics, Inc. today announced new preclinical data demonstrating that ATSP-9172, its Stapled Peptide inhibitor of HIF-1α-dependent transcription, exhibits on-target binding activity, favorable pharmacokinetic properties and potent in vivo efficacy in a human prostate cancer model.
Moerae Matrix Inc. announced today the initiation of its second Phase 1 clinical trial with MMI-0100, a first-in-class inhibitor of MAPKAP kinase 2 (MK2) that is being developed for pulmonary disorders characterized by inflammation and fibrosis. The study, conducted in the United Kingdom, is a double-blind, two-way cross-over design lipopolysaccharide (LPS) challenge study further evaluating the safety and tolerability of MMI-0100 when given via inhalation to healthy subjects who smoke.
If dead cells accumulate in the body, they can contribute to inflammation and pre-dispose individuals to multiple chronic inflammatory conditions such as rheumatoid arthritis, cardiovascular diseases, Crohn's disease or lupus by uncharacterized pathways.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Schering-Plough's brain tumor treatment Temodar® (temozolomide). The Court found that U.S. Patent No. 5,260,291 is not enforceable due to prosecution laches and inequitable conduct.
A radiologic technology, which functions like a 'human GPS system,' and provides more precise results while using less radiation, is being used to treat patients with symptomatic uterine fibroids exclusively at Paoli Hospital. Dr. Atul Gupta, director of interventional radiology, is treating patients as part of a first-ever clinical trial.
› Verified 7 days ago
| Entity Name | Medstar Medical Group Radiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326450156 PECOS PAC ID: 1557589157 Enrollment ID: O20140826000263 |
News Archive
Aileron Therapeutics, Inc. today announced new preclinical data demonstrating that ATSP-9172, its Stapled Peptide inhibitor of HIF-1α-dependent transcription, exhibits on-target binding activity, favorable pharmacokinetic properties and potent in vivo efficacy in a human prostate cancer model.
Moerae Matrix Inc. announced today the initiation of its second Phase 1 clinical trial with MMI-0100, a first-in-class inhibitor of MAPKAP kinase 2 (MK2) that is being developed for pulmonary disorders characterized by inflammation and fibrosis. The study, conducted in the United Kingdom, is a double-blind, two-way cross-over design lipopolysaccharide (LPS) challenge study further evaluating the safety and tolerability of MMI-0100 when given via inhalation to healthy subjects who smoke.
If dead cells accumulate in the body, they can contribute to inflammation and pre-dispose individuals to multiple chronic inflammatory conditions such as rheumatoid arthritis, cardiovascular diseases, Crohn's disease or lupus by uncharacterized pathways.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Schering-Plough's brain tumor treatment Temodar® (temozolomide). The Court found that U.S. Patent No. 5,260,291 is not enforceable due to prosecution laches and inequitable conduct.
A radiologic technology, which functions like a 'human GPS system,' and provides more precise results while using less radiation, is being used to treat patients with symptomatic uterine fibroids exclusively at Paoli Hospital. Dr. Atul Gupta, director of interventional radiology, is treating patients as part of a first-ever clinical trial.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Albert Victor Porambo, MD 3905 Fox Valley Dr, Rockville, MD 20853-3206 Ph: (301) 774-4764 | Dr Albert Victor Porambo, MD 3905 Fox Valley Dr, Rockville, MD 20853-3206 Ph: (301) 774-4764 |
News Archive
Aileron Therapeutics, Inc. today announced new preclinical data demonstrating that ATSP-9172, its Stapled Peptide inhibitor of HIF-1α-dependent transcription, exhibits on-target binding activity, favorable pharmacokinetic properties and potent in vivo efficacy in a human prostate cancer model.
Moerae Matrix Inc. announced today the initiation of its second Phase 1 clinical trial with MMI-0100, a first-in-class inhibitor of MAPKAP kinase 2 (MK2) that is being developed for pulmonary disorders characterized by inflammation and fibrosis. The study, conducted in the United Kingdom, is a double-blind, two-way cross-over design lipopolysaccharide (LPS) challenge study further evaluating the safety and tolerability of MMI-0100 when given via inhalation to healthy subjects who smoke.
If dead cells accumulate in the body, they can contribute to inflammation and pre-dispose individuals to multiple chronic inflammatory conditions such as rheumatoid arthritis, cardiovascular diseases, Crohn's disease or lupus by uncharacterized pathways.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. District Court for the District of Delaware has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Schering-Plough's brain tumor treatment Temodar® (temozolomide). The Court found that U.S. Patent No. 5,260,291 is not enforceable due to prosecution laches and inequitable conduct.
A radiologic technology, which functions like a 'human GPS system,' and provides more precise results while using less radiation, is being used to treat patients with symptomatic uterine fibroids exclusively at Paoli Hospital. Dr. Atul Gupta, director of interventional radiology, is treating patients as part of a first-ever clinical trial.
› Verified 7 days ago
Dr. Charles Finder, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1350 Piccard Dr, Rockville, MD 20850 Phone: 240-276-3263 | |
Marie K Gurka, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9905 Medical Center Dr Ste 100, Rockville, MD 20850 Phone: 301-309-6765 Fax: 301-309-2230 | |
Dr. Irwin Marc Feuerstein, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 619 Watts Branch Pkwy, Rockville, MD 20854 Phone: 202-782-9128 Fax: 301-251-9060 | |
Dr. Obi Nobi, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 11400 Rockville Pike, Suite 105, Rockville, MD 20852 Phone: 301-984-9009 Fax: 901-984-3042 | |
Sidney J Pion, MD Radiology Medicare: Medicare Enrolled Practice Location: 4110 Aspen Hill Rd, Suite 200, Rockville, MD 20853 Phone: 301-438-5150 Fax: 301-460-0199 | |
Dr. Myria Petrou, MBCHB Radiology Medicare: Accepting Medicare Assignments Practice Location: 14995 Shady Grove Rd, Rockville, MD 20850 Phone: 301-217-0500 |